Shire moves within MA; Bosch Packaging expands in China;

> Shire expects to complete construction of its newest building next month and begin moving 250 employees from Cambridge to Lexington, MA. Story

> Process provider Bosch Packaging Technology is expanding operations in China and enlarging its site in Hangzhou, Zhejiang province, adding 1,400 square meters for 120 workers. Story

> The FDA has walloped API-maker Yag-Mag Labs of India with a warning letter and an import alert. Warning Letter 320-11-20

> Stem-cell treatment developer Mesoblast says it will form a manufacturing alliance with Lonza Group as it prepares to mass-produce its regenerative therapies. Release

> Nigerian medicine distributor Greenlife Pharmaceutical and Indian drugmaker Bliss GVS will use Sproxil's anti-counterfeiting platform MAS (for medicine authentication system) with the antimalarial drug Lonart-DS. Article

> GlaxoSmithKline ($GSK) will collaborate with Formula 1 racing developer McLaren Group, focusing initially on innovation in manufacturing and R&D. Story

> Dozens of firefighters and some employees of Orchid Chemical and Pharmaceuticals fought a fire for 5 hours in Sholinganallur, south of Chennai, containing damage to computers, lab equipment and furniture; the fire was caused by heating equipment left on overnight. Item

> GSK ($GSK) has opened the Department of Soft Gelatinous Capsules in Poznan, Poland. More

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot.